Your browser is out-of-date!

Update your browser to view this website correctly.

1Cookies

2Disclaimer

Bellevue Healthcare ETF

Key industry with high relevance (10% ofglobal GDP) and measurable innovationpower

Active management by a highly experienced team of specialists

Flexible trading on SIX Swiss Exchange (CHF and USD) and Deutsche Börse Xetra (EUR)

Indexed performance (as at: 13.11.2025)

NAV: USD 11.27 (25.11.2025)


01 Jan 2010 - 01 Jan 2010
An error occurred - no data to display
CARE
MSCI World Healthcare

Cumulative performance (13.11.2025)

CAREMSCI World Healthcare
1M4.13%4.66%
YTDn.a.n.a.
1 yearn.a.n.a.
Since Inception10.65%10.93%

Investment Focus

The investment objective of the Fund is to provide long-term capital growth from an actively managed portfolio comprising listed equity and equity-related securities of companies in the healthcare sector. The healthcare sector includes companies from the pharmaceutical, medical technology, biotechnology and related healthcare industries. The Fund promotes ESG characteristics as part of its implementation of the aforementioned investment policies.Show moreShow less

The Fund’s investment objective is to generate attractive and competitive long-term capital growth. It is particularly suited to investors with an investment horizon of at least 5 years. The Fund is exposed to the risks typical of equity investments.

General Information

Investment ManagerBellevue Asset Management AG
CustodianNorthern Trust
Fund AdministratorNorthern Trust
Launch date15.09.2025
Year end closing31. Mar
Management Fee0.55%
ISIN numberIE000R6TN604
BloombergCARE SW
WKNA41CY1

Legal Information

Legal formIrish Collective Asset-management Vehicle
SFDR categoryArticle 8

Top 10 positions

Eli Lilly
Johnson & Johnson
AbbVie
UnitedHealth Group
AstraZeneca
Roche
Thermo Fisher
Abbott Laboratories
Merck & Co
Intuitive Surgical
9.9%
6.6%
5.4%
4.4%
4.0%
3.8%
3.3%
3.2%
3.2%
3.1%

Market capitalization

5 - 15 bn
15 - 20 bn
> 20 bn
0.8%
1.0%
97.7%

Geographic breakdown

United States
Switzerland
Great Britain
Japan
France
Denmark
Netherlands
Australia
Belgium
Germany
Finland
Sweden
Cash
70.9%
9.8%
5.8%
3.5%
2.9%
2.3%
0.9%
0.8%
0.7%
0.6%
0.3%
0.3%
1.1%

Breakdown by sector

Pharma
Medtech
Services
Biotechnology
Life Sciences Tools
Generics/Spec.Pharma
Healthcare Technology
Other
Cash
45.3%
22.8%
13.1%
12.0%
3.6%
1.3%
0.7%
0.2%
1.1%

Currency

USD
CHF
GBP
EUR
JPY
DKK
AUD
ILS
SEK
CASH
70.5%
9.8%
5.8%
5.4%
3.5%
2.3%
0.8%
0.4%
0.3%
1.1%

Benefits

  • Participate in the attractive growth dynamics of the global healthcare sector.
  • Access to a structurally relevant sector with a proven track record of innovation.
  • Unlock additional return potential through active management driven by conviction-based investment decisions.
  • Benefit from the advantages of an ETF (exchange-traded, cost-efficient, transparent).
  • Bellevue Asset Management - your specialist for healthcare investments since 1993.

Risks

  • The fund invests in equities. Equities are subject to price fluctuations and so are also exposed to the risk of price losses.
  • As an actively managed ETF, the fund's performance may deviate from the reference benchmark.
  • The fund invests in foreign currencies, which means a corresponding degree of currency risk against the reference currency.
  • The fund may invest a proportion of its assets in financial instruments that might under certain circumstances have a relatively low level of liquidity, which can in turn affect the fund’s liquidity.
  • The fund may engage in derivatives transactions. The increased opportunities gained come with an increased risk of losses.
Loading...

Show moreShow less

  • Co-Lead Portfolio Manager

    Marcel Fritsch

    Marcel Fritsch has been with Bellevue Asset Management since 2008. He is head of healthcare funds & mandates and co-lead portfolio manager of the Bellevue Medtech & Services, Bellevue Digital Health and Bellevue AI Health funds. Prior to that, he worked as a consultant at Deloitte Touche Tohmatsu for over 3 years. His tasks in this function included analysis of business strategies, assessment of organizational structures and the valuation of companies in the run-up to corporate transactions. Marcel Fritsch holds a degree in business administration from the University of St. Gallen (HSG).
  • Co-Lead Portfolio Manager

    Terence McManus

    Dr Terence McManus joined Bellevue Asset Management in 2022 and is lead portfolio manager of the funds Bellevue Diversified Healthcare, Bellevue Healthcare Strategy/Sustainable and portfolio manager of the Bellevue Obesity Solutions fund. Prior to this, he has 12 years of experience within healthcare-specific investing and analysis at Jefferies Investment Bank, Credit Suisse, Julius Baer and most recently at J. Safra Sarasin where he managed a sustainable health fund. Terence started his career as a scientist focused on drug discovery. He holds a PhD in Neuroscience from the University of Southampton, UK.
1

These insights might interest you